GlobeImmune Revenue, Profits - GBIM Quarterly Income Statement

Add to My Stocks
$0.57 $0 (0%) GBIM stock closing price Jun 21, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking GlobeImmune stock price alone is not sufficient. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. Like any other income statement, the GBIM income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of 0 when compared to the same period in the past. The operating expenses as shown in the GlobeImmune profit and loss statement for 2016 Q1 total to $0. This line item shows that the operating expenses has decreased compared with last year. Also check: GlobeImmune assets and GlobeImmune free cash flow.

View and download details of revenue and profits for GlobeImmune for latest & last 40 quarters.
show more
Fiscal year is Jan - Dec2016 Q12015 Q4
GlobeImmune Revenues or Net Sales
-1.05M
Cost Of Goods Sold (COGS)--
GlobeImmune Gross Profit
--
Research & Development Expense--
Selling General & Admin Expense-1.15M
Income Before Depreciation Depletion Amortization-0.84M-0.77M
Depreciation Depletion Amortization--
Non Operating Income--
Interest Expense--
GlobeImmune Pretax Income
-0.86M-0.79M
Provision for Income Taxes--
MinorityInterest--
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations-0.86M-0.8M
Extraordinary Items & Discontinued Operations--
GlobeImmune Profit/ Loss (Net Income)
-0.86M-0.8M
Average Shares used to compute Diluted EPS5.75M5.68M
Average Shares used to compute Basic EPS5.75M5.68M
Income Before Nonrecurring Items-0.86M-0.8M
Income from Nonrecurring Items--
GlobeImmune Earnings Per Share Basic Net
-0.15-0.14
GlobeImmune Earnings Per Share Diluted Net
-0.15-0.14
EPS Diluted Before Nonrecurring Items-0.15-0.14
Preferred Dividends Acc Pd--
Dividends Common--
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

GlobeImmune stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the GlobeImmune revenue chart, as isn't the case with GlobeImmune indicates a sagging business. One needs to compare the QoQ topline or sales growth of GBIM stock with its peers like ACUR stock and PARNF stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. GBIM stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The GBIM financials along with GlobeImmune historical stock prices provide a lot of details about the firm.

GlobeImmune Income Statement - Key Financial Ratios